A5032092567- NF-κB Signaling Pathways
- Mosquito-borne diseases and control
- Effects and risks of endocrine disrupting chemicals
- Peroxisome Proliferator-Activated Receptors
- Toxic Organic Pollutants Impact
- Coronary Interventions and Diagnostics
- HIV Research and Treatment
- Carcinogens and Genotoxicity Assessment
- Venous Thromboembolism Diagnosis and Management
- Acute Myocardial Infarction Research
- Immune Response and Inflammation
- interferon and immune responses
University of Manitoba
2019-2025
TILRR (Toll-like Interleukin-1 Receptor Regulator) is a modulator of many genes in NF-κB (nuclear factor kappa-light-chain-enhancer activated B cells) signaling. It promotes the production inflammatory mediators and migration immune cells. Recently, we showed that protein circulates human blood. Thus, it could influence systemic inflammation. Systemic mucosal inflammations increase susceptibility to HIV infection. In this study, analyzed levels archived plasma samples women enrolled Pumwani...
Background: TILRR (Toll-like Interleukin-1 Receptor Regulator) is a modulator of many genes in NF-κB (nuclear factor kappa-light-chain-enhancer activated B cells) signaling. It promotes the production inflammatory mediators and migration immune cells. Recently, we showed that protein circulates human blood. Thus, it could modulate systemic inflammation. Systemic mucosal inflammations increase susceptibility to HIV infection. In this study, analyzed levels archived plasma samples women...